-
Immutep Limited (IMMP) PT Raised to $7 at Baird
-
Immutep (IMMP) Receives A$3.6M R&D Tax Incentive from French Government
-
Immutep (IMMP) Announces Successful Meeting with FDA on Phase III Design in Non-Small Cell Lung Cancer
-
Immutep Limited (IMMP) PT Lowered to $6 at Baird

